-

Summit Partners Announces Global Promotions

BOSTON & MENLO PARK, Calif. & LONDON--(BUSINESS WIRE)--Summit Partners, a leading alternative investment firm, today announced the promotion of five professionals globally. Scott Ferguson and Sergio Mur were promoted to Principal; and Chris Bon, Olivia Ley and Jono Pagden were promoted to Vice President.

“We are pleased to recognize the achievements of Scott, Sergio, Chris, Olivia and Jono with these well-deserved promotions,” said Peter Chung, Managing Director and Chief Executive Officer of Summit Partners. “These talented professionals have served our limited partners and our portfolio companies with distinction. We are proud of the positive impact they’ve made at Summit Partners and beyond.”

Scott Ferguson has been promoted to Principal. Scott joined Summit as an Associate in 2009, was promoted to Senior Associate in 2012 and returned to Summit as a Vice President in 2015. Scott is based in Summit’s Menlo Park office and focuses primarily on the technology sector. His board and investment experience includes Calypso Technology, HelpSystems (acquired by H.I.G. Capital), MercuryGate, Perforce Software (acquired by Clearlake Capital), Teaching Strategies and Trintech. Prior to Summit, Scott worked for Piper Jaffray in the Technology Investment Banking Group. He holds a BS in finance from the University of Kansas and an MBA from the Kellogg School of Management at Northwestern University.

Sergio Mur has been promoted to Principal. Sergio joined Summit’s London office as a Vice President in 2016. He has been an active member of Summit’s Peak Performance Group, leading engagements with numerous Summit portfolio companies including Advance Medical (acquired by Teladoc), Signavio, DentalPro (acquired by BC Partners), Syncron and Siteimprove. Prior to Summit, Sergio worked as a Vice President of European Operations at Cerberus Capital, in business development at Privalia (acquired by vente-privee.com), planning and analysis at TJX Companies (NYSE: TJX) and M&A at J.P. Morgan. Sergio holds a CEMS Master in international management from St. Gallen University in Switzerland and a Master in business management from ESADE Business School in Spain.

Chris Bon has been promoted to Vice President. Chris joined Summit’s London office as an Associate in 2016 and was promoted to Senior Associate in 2019. He is a member of the firm’s Growth Products & Services team. His investment experience includes Normec, OnRobot, ProGlove and Sipartech (acquired by Blackstone). Prior to Summit, Chris worked in M&A advisory at J.P. Morgan. He holds a BCom in economics from the University of Toronto and an MSc in finance from HEC Paris.

Olivia Ley has been promoted to Vice President. Olivia joined Summit’s Menlo Park office as an Associate in 2017 and was promoted to Senior Associate in 2019. She is a member of the firm’s Healthcare & Life Sciences team. Her portfolio experience includes Healthline Media (acquired by Red Ventures). Prior to Summit, Olivia worked at Castlight Health and The Advisory Board Company. She holds a BA in English literature from Princeton University.

Jono Pagden has been promoted to Vice President. Jono joined Summit’s London office as an Associate in 2016 and was promoted to Senior Associate in 2019. He is a member of the firm’s Healthcare & Life Sciences team. Jono’s investment experience includes Advance Medical (acquired by Teladoc) and zahneins (acquired by PAI Partners). Prior to Summit, Jono worked on the Retail/Healthcare and U.K. M&A teams at Goldman Sachs. He holds a Bachelor of Business Science, with honors, in accounting and finance from the University of Cape Town.

About Summit Partners

Founded in 1984, Summit Partners is a global alternative investment firm that is currently managing more than $19 billion in capital dedicated to growth equity, fixed income and public equity opportunities. Summit invests across growth sectors of the economy and has invested in more than 500 companies in technology, healthcare, consumer, financial and business services, and other growth industries. Summit maintains offices in North America and Europe, and invests in companies around the world. For more Summit stories and to learn about #TheSummitPartnersNetwork, visit www.summitpartners.com or follow on LinkedIn.

In the United States of America, Summit Partners operates as an SEC-registered investment advisor. In the United Kingdom, this document is issued by Summit Partners LLP, a firm authorized and regulated by the Financial Conduct Authority. Summit Partners LLP is a limited liability partnership registered in England and Wales with registered number OC388179 and its registered office is at 11-12 Hanover Square, London, W1S 1JJ, UK. This document is intended solely to provide information regarding Summit Partners’ potential financing capabilities for prospective portfolio companies.

Contacts

Meg Devine
+1 617 824 1047
mdevine@summitpartners.com

Summit Partners


Release Summary
Summit Partners, a leading alternative investment firm, today announced the promotion of five professionals globally.
Release Versions

Contacts

Meg Devine
+1 617 824 1047
mdevine@summitpartners.com

Social Media Profiles
More News From Summit Partners

Summit Partners Announces Global Promotions

BOSTON & MENLO PARK, Calif. & NEW YORK & LONDON--(BUSINESS WIRE)--Summit Partners, a leading growth-focused alternative investment firm, today announced the promotion of thirteen professionals across the firm’s global offices. The firm has promoted Chris Bon, Meg Devine, Ross Murphy and Jono Pagden to Partner; Devin O’Connor Deane, Irina Müller and Nik Ohri to Principal; and Luke Farrugia, Grace Gwozdz, Patrick McLaughlin, Max Miller, Alberto Reyes and Paul-Hugo Thiboult to Vice President. “We...

Summit Partners Announces Growth Investment in Dreampath Diagnostics to Accelerate Digital Transformation in Anatomical Pathology

LONDON & BOSTON & STRASBOURG, France--(BUSINESS WIRE)--Summit Partners today announced a growth investment in Dreampath Diagnostics, a leading healthcare technology company focused on digitizing workflows in anatomical pathology laboratories. The investment will support the company’s plans to accelerate global growth, scale operations and expand its commercial reach and product portfolio. Founded in 2012, Dreampath offers a patented suite of traceability solutions and consumables designed to au...

RIS Rx Announces Growth Investment from Summit Partners to Combat Revenue Leakage in Pharma Patient Affordability Programs

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--RIS Rx, a healthcare technology company pioneering solutions to reduce revenue leakage in pharmaceutical gross-to-net spread, today announced a significant growth investment from Summit Partners. This partnership will support RIS Rx’s continued innovation and growth in service of the company’s commitment to improving patient access to treatment, one prescription at a time. Founded in 2020 by pharmacists Gerard Rivera and Stephen Hom, RIS Rx was born out o...
Back to Newsroom